Submission Details
| 510(k) Number | K051141 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 04, 2005 |
| Decision Date | July 26, 2005 |
| Days to Decision | 83 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
K051141 is an FDA 510(k) clearance for the WHOLE PTH (1-84) SPECIFIC IMMUNOCHEMILUMINOMETRIC ASSAY (ICMA), MODEL 3KG002, a Radioimmunoassay, Parathyroid Hormone (Class II — Special Controls, product code CEW), submitted by Scantibodies Laboratory, Inc. (Santee, US). The FDA issued a Cleared decision on July 26, 2005, 83 days after receiving the submission on May 4, 2005. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1545.
| 510(k) Number | K051141 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 04, 2005 |
| Decision Date | July 26, 2005 |
| Days to Decision | 83 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Statement |
| Product Code | CEW — Radioimmunoassay, Parathyroid Hormone |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1545 |